BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 20382700)

  • 1. Overexpression of galectin-7, a myoepithelial cell marker, enhances spontaneous metastasis of breast cancer cells.
    Demers M; Rose AA; Grosset AA; Biron-Pain K; Gaboury L; Siegel PM; St-Pierre Y
    Am J Pathol; 2010 Jun; 176(6):3023-31. PubMed ID: 20382700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Galectins as markers of aggressiveness of mouse mammary carcinoma: towards a lectin target therapy of human breast cancer.
    Moiseeva EV; Rapoport EM; Bovin NV; Miroshnikov AI; Chaadaeva AV; Krasilshschikova MS; Bojenko VK; Bijleveld C; van Dijk JE; Den Otter W
    Breast Cancer Res Treat; 2005 Jun; 91(3):227-41. PubMed ID: 15952056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Galectins-1 and -3 and their ligands in tumor biology. Non-uniform properties in cell-surface presentation and modulation of adhesion to matrix glycoproteins for various tumor cell lines, in biodistribution of free and liposome-bound galectins and in their expression by breast and colorectal carcinomas with/without metastatic propensity.
    André S; Kojima S; Yamazaki N; Fink C; Kaltner H; Kayser K; Gabius HJ
    J Cancer Res Clin Oncol; 1999; 125(8-9):461-74. PubMed ID: 10480338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bisected, complex N-glycans and galectins in mouse mammary tumor progression and human breast cancer.
    Miwa HE; Koba WR; Fine EJ; Giricz O; Kenny PA; Stanley P
    Glycobiology; 2013 Dec; 23(12):1477-90. PubMed ID: 24037315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Galectin-9 as a prognostic factor with antimetastatic potential in breast cancer.
    Irie A; Yamauchi A; Kontani K; Kihara M; Liu D; Shirato Y; Seki M; Nishi N; Nakamura T; Yokomise H; Hirashima M
    Clin Cancer Res; 2005 Apr; 11(8):2962-8. PubMed ID: 15837748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myoepithelial cell-specific expression of stefin A as a suppressor of early breast cancer invasion.
    Duivenvoorden HM; Rautela J; Edgington-Mitchell LE; Spurling A; Greening DW; Nowell CJ; Molloy TJ; Robbins E; Brockwell NK; Lee CS; Chen M; Holliday A; Selinger CI; Hu M; Britt KL; Stroud DA; Bogyo M; Möller A; Polyak K; Sloane BF; O'Toole SA; Parker BS
    J Pathol; 2017 Dec; 243(4):496-509. PubMed ID: 29086922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nestin is expressed in the basal/myoepithelial layer of the mammary gland and is a selective marker of basal epithelial breast tumors.
    Li H; Cherukuri P; Li N; Cowling V; Spinella M; Cole M; Godwin AK; Wells W; DiRenzo J
    Cancer Res; 2007 Jan; 67(2):501-10. PubMed ID: 17234757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Galectin-9, a novel prognostic factor with antimetastatic potential in breast cancer.
    Yamauchi A; Kontani K; Kihara M; Nishi N; Yokomise H; Hirashima M
    Breast J; 2006; 12(5 Suppl 2):S196-200. PubMed ID: 16959001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Galectin-7 in Epithelial Homeostasis and Carcinomas.
    Advedissian T; Deshayes F; Viguier M
    Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29257082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-grade carcinomas of the breast showing patterns of mixed ductal and myoepithelial differentiation (including myoepithelial cell-rich carcinoma of the breast).
    Coyne JD; Dervan PA; Barr L
    Histopathology; 2004 Jun; 44(6):580-4. PubMed ID: 15186273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Developmental biology: cell fate in the mammary gland.
    Tong Q; Hotamisligil GS
    Nature; 2007 Feb; 445(7129):724-6. PubMed ID: 17301782
    [No Abstract]   [Full Text] [Related]  

  • 12. Different fractions of human serum glycoproteins bind galectin-1 or galectin-8, and their ratio may provide a refined biomarker for pathophysiological conditions in cancer and inflammatory disease.
    Carlsson MC; Balog CI; Kilsgård O; Hellmark T; Bakoush O; Segelmark M; Fernö M; Olsson H; Malmström J; Wuhrer M; Leffler H
    Biochim Biophys Acta; 2012 Sep; 1820(9):1366-72. PubMed ID: 22285770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of galectin-7 is induced in breast cancer cells by mutant p53.
    Campion CG; Labrie M; Lavoie G; St-Pierre Y
    PLoS One; 2013; 8(8):e72468. PubMed ID: 23967302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Obesity reversibly depletes the basal cell population and enhances mammary epithelial cell estrogen receptor alpha expression and progenitor activity.
    Chamberlin T; D'Amato JV; Arendt LM
    Breast Cancer Res; 2017 Nov; 19(1):128. PubMed ID: 29187227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen receptor beta growth-inhibitory effects are repressed through activation of MAPK and PI3K signalling in mammary epithelial and breast cancer cells.
    Cotrim CZ; Fabris V; Doria ML; Lindberg K; Gustafsson JÅ; Amado F; Lanari C; Helguero LA
    Oncogene; 2013 May; 32(19):2390-402. PubMed ID: 22751110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Galectin signatures contribute to the heterogeneity of breast cancer and provide new prognostic information and therapeutic targets.
    Grosset AA; Labrie M; Vladoiu MC; Yousef EM; Gaboury L; St-Pierre Y
    Oncotarget; 2016 Apr; 7(14):18183-203. PubMed ID: 26933916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Galectin-3 coats the membrane of breast cells and makes a signature of tumours.
    Simone G; Malara N; Trunzo V; Renne M; Perozziello G; Di Fabrizio E; Manz A
    Mol Biosyst; 2014 Feb; 10(2):258-65. PubMed ID: 24281352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Semaphorin 7A Promotes Macrophage-Mediated Lymphatic Remodeling during Postpartum Mammary Gland Involution and in Breast Cancer.
    Elder AM; Tamburini BAJ; Crump LS; Black SA; Wessells VM; Schedin PJ; Borges VF; Lyons TR
    Cancer Res; 2018 Nov; 78(22):6473-6485. PubMed ID: 30254150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myoepithelial molecular markers in human breast carcinoma PMC42-LA cells are induced by extracellular matrix and stromal cells.
    Lebret SC; Newgreen DF; Waltham MC; Price JT; Thompson EW; Ackland ML
    In Vitro Cell Dev Biol Anim; 2006; 42(10):298-307. PubMed ID: 17316063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mammary stem cells and progenitors: targeting the roots of breast cancer for prevention.
    Tharmapalan P; Mahendralingam M; Berman HK; Khokha R
    EMBO J; 2019 Jul; 38(14):e100852. PubMed ID: 31267556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.